The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 35, No. 10, pp. 1194-1198. DOI 10.1345/aph.10359
© 2001 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushner, J.
Right arrow Articles by Snyder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushner, J.
Right arrow Articles by Snyder, C.


Research Articles

Seizures associated with fluoroquinolones

JM Kushner, HJ Peckman, and CR Snyder

OBJECTIVE: To report two cases of seizures following administration of levofoxacin and ciprofloxacin. CASE SUMMARY: A 75-year-old white woman admitted to the hospital was prescribed levofloxacin for ischemic toes. After receiving three doses of oral levofloxacin, the patient experienced a seizure. One month later, the patient was rechallenged with ciprofloxacin and again experienced a seizure. The patient was hypomagnesemic and had elevated serum creatinine at the time of both seizures, and was hyponatremic during the second seizure. A 74-year-old white woman admitted to the hospital was prescribed levofloxacin for bacterial pneumonia. After five doses, the patient experienced a seizure. The woman had no electrolyte imbalances at the time of the seizure and no history of a seizure disorder. DISCUSSION: Quinolone antibiotics vary in their ability to induce seizures, with trovafloxacin having the greatest potential and levofloxacin possibly having the least potential. Neither patient had a history of a previous seizure disorder. Electrolyte imbalances are common with previous reports of fluoroquinolone-induced seizures. CONCLUSIONS: Although levofloxacin monotherapy has not been implicated in inducing seizures, it appears to be the causative agent in the second case. In the first case, the quinolones may have been a necessary, but not sufficient, cause in a patient with electrolyte abnormalities. Risk factors for fluoroquinolone-induced seizures may Include seizure history, electrolyte imbalances,dose unadjusted for renal insufficiency, and concomitant treatment with agents that lower the seizure threshold.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. J Barrett and I. S Login
Gemifloxacin-Associated Neurotoxicity Presenting as Encephalopathy
Ann. Pharmacother., April 1, 2009; 43(4): 782 - 784.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. J Mehlhorn and D. A Brown
Safety Concerns with Fluoroquinolones
Ann. Pharmacother., November 1, 2007; 41(11): 1859 - 1866.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
M. J Christie, K. Wong, R. H Ting, P. Y Tam, and T. G. Sikaneta
Generalized Seizure and Toxic Epidermal Necrolysis Following Levofloxacin Exposure
Ann. Pharmacother., May 1, 2005; 39(5): 953 - 955.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
A. M. Cook
Pharmacokinetic Alterations of Antimicrobials in the Critically Ill
Journal of Pharmacy Practice, April 1, 2005; 18(2): 75 - 83.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. H Seto, J. C Song, and S. S Guest
Ertapenem-Associated Seizures in a Peritoneal Dialysis Patient
Ann. Pharmacother., February 1, 2005; 39(2): 352 - 356.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. L Long, M. A Raebel, D. W Price, and D. J Magid
Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease
Ann. Pharmacother., May 1, 2004; 38(5): 853 - 858.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. A Quigley and J. R Lederman
Possible Gatifloxacin-Induced Seizure
Ann. Pharmacother., February 1, 2004; 38(2): 235 - 237.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2001 by Harvey Whitney Books Company.